Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Autosomal Dominant Optic Atrophy. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Clinical ResearchTrials Active, No NIH Grants
4 clinical trials registered but no NIH-funded clinical or translational research grants found for autosomal dominant optic atrophy. Trials may be industry-sponsored or funded through non-NIH sources.
Biomarker / DiagnosticsPublished, Not NIH-Funded
10 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for autosomal dominant optic atrophy. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
11 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for autosomal dominant optic atrophy. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
9 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for autosomal dominant optic atrophy. Existing research activity suggests this may be a viable area for grant applications.
Translational / Drug DevelopmentPublished, Not NIH-Funded
6 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for autosomal dominant optic atrophy. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(2 grants)
These grants mention Autosomal Dominant Optic Atrophy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(2)
OtherR01Active
Advancing novel therapies for optic neuropathy with a nonhuman primate model
Thomasy, Sara·UNIVERSITY OF CALIFORNIA AT DAVIS·DAVIS, CA
